Furthermore, GCH1 overexpression and BH4 levels elevation in GBM cells increase proliferation and decrease survival in an intracranial GBM-mouse model, which is correlated with brain tumor-initiating cells maintenance and ROS suppression [56]. This evidence concerns the gene GCH1 and glioblastoma.